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Background: Small non-coding RNAs (sRNAs) have attracted attention as a new class of gene regulators in both
eukaryotes and bacteria. Genome-wide screening methods have been successfully applied in Gram-negative
bacteria to identify sRNA regulators. Many sRNAs are well characterized, including their target mRNAs and mode of
action. In comparison, little is known about sRNAs in Gram-positive pathogens. In this study, we identified novel
sRNAs in the exclusively human pathogen Streptococcus pyogenes M49 (Group A Streptococcus, GAS M49),
employing a whole genome intergenic tiling array approach. GAS is an important pathogen that causes diseases
ranging from mild superficial infections of the skin and mucous membranes of the naso-pharynx, to severe toxic
and invasive diseases.
Results: We identified 55 putative sRNAs in GAS M49 that were expressed during growth. Of these, 42 were novel.
Some of the newly-identified sRNAs belonged to one of the common non-coding RNA families described in the
Rfam database. Comparison of the results of our screen with the outcome of two recently published bioinformatics
tools showed a low level of overlap between putative sRNA genes. Previously, 40 potential sRNAs have been
reported to be expressed in a GAS M1T1 serotype, as detected by a whole genome intergenic tiling array approach.
Our screen detected 12 putative sRNA genes that were expressed in both strains. Twenty sRNA candidates
appeared to be regulated in a medium-dependent fashion, while eight sRNA genes were regulated throughout
growth in chemically defined medium. Expression of candidate genes was verified by reverse transcriptase-qPCR.
For a subset of sRNAs, the transcriptional start was determined by 50 rapid amplification of cDNA ends-PCR
(RACE-PCR) analysis.
Conclusions: In accord with the results of previous studies, we found little overlap between different screening
methods, which underlines the fact that a comprehensive analysis of sRNAs expressed by a given organism requires
the complementary use of different methods and the investigation of several environmental conditions. Despite a
high conservation of sRNA genes within streptococci, the expression of sRNAs appears to be strain specific.
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In recent years, the role of small non-coding RNAs
(sRNAs) in regulation of bacterial gene expression has
become more evident; however, the large number of sRNAs
identified in different bacterial species was unexpected
[1-3]. Even though sRNAs were conventionally regarded
as inhibitory antisense regulators, a significant number of
sRNAs that activate bacterial gene expression have been
characterized [4]. Furthermore, regulatory mechanisms
include both the stabilization and destabilization of target
transcripts [5]. Bacterial sRNAs influence the expression
of genes involved in processes as diverse as stress
response, sugar metabolism, and surface composition
[6-10]. With sRNAs representing a whole new level of
post-transcriptional regulation, it is no surprise that these
molecules play an important role in the tightly controlled
expression of virulence factors in many pathogens [11,12].
We were interested in the regulatory sRNAome of
Streptococcus pyogenes (group A streptococci, GAS), a
common, exclusively human pathogen that causes a var-
iety of diseases. GAS is responsible for mild superficial
infections of the skin (impetigo contagiosa) and mucosal
membranes (pharyngitis and tonsillitis). Additionally,
there is a high global burden of severe GAS diseases
such as post-streptococcal sequelae, and severe systemic
(streptococcal toxic-shock-like syndrome) or invasive
infections (necrotizing fasciitis), leading to over 500,000
deaths per year [13,14]. The controlled expression of
virulence factors plays a role in GAS infection, persistence
in the host, and development of invasive diseases, which
makes the investigation of virulence factors and their regu-
lation a research priority. GAS expresses a large number of
virulence factor genes coding for a variety of proteins,
including surface components, lytic enzymes, proteinases,
cytotoxins, superantigens, and immunoprotective proteins,
that are controlled at least partially by the 30 stand-alone
transcriptional regulators and 13 two-component systems
identified to date in GAS [15]. Virulence factor expression
in GAS is highly responsive to environmental conditions
and greatly depends on the growth phase.
Little is known, however, about the importance of
sRNAs for virulence-related gene regulation in GAS. An
overview of small RNAs in streptococci is nicely
presented by Le Rhun and Charpentier [16]. Several
individual sRNAs have been identified in GAS [17,18],
with many more predicted by bioinformatic screens
[12,19]. Previous analysis of sRNA expression in a GAS
M1T1 serotype using an intergenic tiling array approach
identified 40 potential sRNAs, with a very low predicted
overlap with candidate genes [20]. The authors
concluded that sRNA expression in GAS is serotype-
dependent. The current work focused on sRNA expression
in the skin isolate GAS M49. An intergenic tiling array
identified 42 novel and 13 known sRNAs. Data from thisexperiment were compared to the results of the former
GAS M1T1 study, and to predictions of two recently
published bioinformatics tools [19,21]. Additionally, we
tested the regulation of sRNA expression in correlation to
growth media and growth phase. We found very little
overlap between the different screening methods, which
underlines the importance of using several complementary
methods, as well as several environmental conditions, to
attain a comprehensive analysis of bacterial sRNAomes.
Results
Identification of sRNAs in the intergenic regions of GAS M49
Custom intergenic tiling arrays representing the genome of
S. pyogenes NZ131 (NCBI accession number: NC_011375)
were designed to detect the expression of potential sRNAs.
A total of 17,823 50-mer probes with an overlap of 15 bp
were synthesized to cover the intergenic regions, with
9,082 probes representing the positive strand and 8,741
probes covering the negative strand. Additionally, 174
probes were designed as control probes covering tRNA
genes or genes coding for known sRNAs. For example, we
probed for fasX [17], SR914400, and SR1754950 [20], all of
which were detected in our experiments. Genedata
Selector software was used to integrate genomes, tiling
array probe sequences, sRNA predictions, and experimental
data. Expression data were analysed in their genomic- and
sequence-based contexts (Genedata AG).
Total RNA for the tiling array experiments was
isolated from GAS M49 grown in chemically defined
medium (CDM). Samples were taken from four
biological replicates during both mid-log growth phase
(OD600= 0.4–0.6) and stationary growth phase (OD600=
1.2). A signal intensity of >300 was set as a threshold. A
positive signal required that a minimum of one probe
specific for one strand showed an intensity above the
threshold in at least three replicates. Intergenic regions
featuring high intensities on both strands were manually
removed following the analysis.
We identified a total of 55 putative sRNAs in GAS
M49 that were expressed during growth in CDM, 42 of
which were novel. Computational functional prediction
revealed that a subset of the newly identified RNAs
included molecules with similarities to one of the
common non-coding RNA families included in the Rfam
database [22]. The database covers functional categories
of non-coding RNAs determined from multiple sequence
alignments. Using the Rfam database, we predicted
functions for 14 putative sRNAs. One of these RNAs was
predicted to be the structural RNA of the bacterial signal
recognition particle (SRP), and another was predicted to be
the bacterial RNase P RNA. Further functional categories
included three T-box leader elements, three CRISPR family
members, one tmRNA, and one endoribonuclease, RNa-
seP_bact_b (Table 1). Table 1 contains a summary of the

















1 sRNASpy490131 141429 141478 49 - ntpK ntpE a
2 sRNASpy490186c 194707 194791 84 + Spy49_0186c speG SRP_bact [37] c
3 sRNASpy490206 216807d 217021 215 +e fasA rnpA MOSES2 fasX [17] b
4 sRNASpy490229 238850 238899 49 + prgA rpsL b
5 sRNASpy490238 248530 248579 49 + Spy49_0238 bacA a
6 sRNASpy490241 251595 251644 49 + rgpG Spy49_0242 a
7 sRNASpy490305 318826 318910 84 + Spy49_0305 Spy49_0306 23S-methyl b
8 sRNASpy490306 319622 319776 154 + Spy49_0306 Spy49_0307 FMN RNA319780 [20] b
9 sRNASpy490348 362857 362906 49 + Spy49_0348 Spy49_0349c MOSES6 a
10 sRNASpy490366c 373806 373855 49 + Spy49_0366c Spy49_0367c -
11 sRNASpy490370 376843 376892 49 + Spy49_0370 Spy49_0371 a
12 sRNASpy490380c 385431 d 385526 95 + e Spy49_0380c mtsA b
13 sRNASpy490388 393522 393571 49 + rplA pyrH a
14 sRNASpy490434 431752 431836 84 + Spy49_0434 thrS T-box b
15 sRNASpy490483c 476503d 476600 97 + e Spy49_0483c bglG b
16 sRNASpy490493 486133 486182 49 + Spy49_0493 ptsK a
17 sRNASpy490504 495351 495400 49 - Spy49_0504 Spy49_0505c a
18 sRNASpy490592 594852 594936 84 + Spy49_0592 pheS b
19 sRNASpy490727 733841 733890 49 - Spy49_0727 Spy49_0728 a
20 sRNASpy490822 820820 820996 d 176 - e Spy49_0822 Spy49_0823 CRISPR RNA772970 [20] c
21 sRNASpy490827 827456 827785 329 + Spy49_0827 Spy49_0828 CRISPR
MOSES14 a
22 sRNASpy490845c 846977 847061 84 + trmE rplJ L10_leader c
23 sRNASpy490948c 941583 941657 d 74 - Spy49_0948c guaA a
24 sRNASpy490957c 950434 950518 84 - e Spy49_0957c Spy49_0958c SR914400 [20] b
25 sRNASpy491007c 1000709 1000828 119 + pcrA Spy49_1008 Glycine b
26 sRNASpy491023c 1019382 1019746 364 + Spy49_1023c Spy49_1024 tmRNA RNA983400 [20] b
27 sRNASpy491061c 184794 184878 84 + Spy49_1061c Spy49_0176 c
28 sRNASpy491095c 1092894 1092943 49 - ptsH nrdH c
29 sRNASpy491122c 1117169 1117218 49 - sodM holA b
30 sRNASpy491163c 1156488 1156537 49 - Spy49_1163c clpE a
31 sRNASpy491167c 1163270 1163319 49 - ileS divIVA T-box -
32 sRNASpy491206c 1201615 1201734 119 - ccdA Spy49_1207c MOSES16 RNA1239700 [20] a
33 sRNASpy491217c 1214010 1214059 49 - Spy49_1217c Spy49_1218c SR1251900 [20] b
34 sRNASpy491243 1246370 1246419 49 + Spy49_1243 Spy49_1244 a
35 sRNASpy491275c 1282084 1282413 329 - Spy49_1275c Spy49_1276c RNaseP_bact b RNA1320100 [20] c
36 sRNASpy491311c 1321638 1321853d 84 - e glyQ Spy49_1312c b
37 sRNASpy491336c 1341554 1341603 49 + rbfA infB b
38 sRNASpy491340c 1346300 1346349 49 - nusA Spy49_1341c b
39 sRNASpy491354 1357803 1357852 49 - manL manM b
40 sRNASpy491357 1360204 1360323 119 + Spy49_1357 serS T-box RNA1439100 [20] b
41 sRNASpy491409c 1413359 1413408 49 - acpS secA a
42 sRNASpy491489c 1489011 1489060 49 + Spy49_1489c Spy49_1491c b
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Table 1 S. pyogenes M49 sRNAs, genomic location, Rfam predictions, and conservation across streptococcal genomes
(Continued)
43 sRNASpy491555c 1528842 1528891 49 - Spy49_1555c Spy49_1556c a
44 sRNASpy491560c 1533843 1533892 49 - Spy49_1560c pyrG a
45 sRNASpy491561c 1535755 1535804 49 - pyrG rpoE c
46 sRNASpy491562c 1536613 1536662 49 - rpoE tig a
47 sRNASpy491591 1571896 1571945 49 - lacR2 Spy49_1592 MOSES18 SR1604140 [20] a
48 sRNASpy491596c 1574723 1574807 84 - rplM 50S Spy49_1597c L13_leader c
49 sRNASpy491671c 1654859 1654908 49 - emm49 Spy49_1672c a
50 sRNASpy491707c 1693440 1693489 49 - Spy49_1707c Spy49_1708 a
51 sRNASpy491713 1698142 1698191 49 + Spy49_1713 Spy49_1714c SR1719800 [20] a
52 sRNASpy491718c 1704471 1704525 54 - ctsR csp a
53 sRNASpy491732c 1724321 1724370 49 + Spy49_1732c rpsB SR1745900 [20] b
54 sRNASpy491738 1733300 1733433d 133 - Spy49_1738 Spy49_1739c SR1754950 [20] b
55 sRNASpy491769c 1763496 1763545 49 + hisS rpmF b




d Transcriptional start site determined by 50 RACE.
e Strand confirmed by gene specific RT-PCR.
Patenge et al. BMC Genomics 2012, 13:550 Page 4 of 14
http://www.biomedcentral.com/1471-2164/13/550information pertaining to all 55 candidate sRNAs, including
the flanking genes, Rfam prediction, and conservation
across other genomes. Five putative sRNA sequences over-
lapped with adjacent ORFs on the same strand. Functional
studies will be necessary to clarify whether the correspond-
ing sRNAs are transcribed independently. The overall GC
content of all 55 sRNA candidate sequences was 38.3%.
This correlates with the GC content of the whole NZ131
genome (38.0%). No specific strand prevalence and no
clustering in specific genomic regions were observed for
the regulatory sRNA genes. The replication-related gene
orientation bias of the protein coding genes [23,24] was
mirrored by the sRNA gene candidates. A circular depic-
tion was created with the Artemis DNAPlotter tool [25]
(Figure 1) to visualize the sRNA genes in the context of the
NZ131 genome.
In a previous bioinformatic approach (MOSES), 20 prob-
able candidates were predicted [19]. In our array analysis,
expression of five of the predicted sRNAs was confirmed
under the conditions studied (Table 1). Furthermore, we
detected 12 streptococcal RNAs that were previously
identified by Perez et al. [20] (Table 1). The phylogenetic
conservation of the putative sRNAs was tested by BLAST
analysis, and the taxonomic classification was presented
following the nomenclature of Facklam [26]. The tiling
array technique with overlapping probes did not allow us to
detect an accurate start site for the respective sRNA genes.
Thus, we described the nucleotides represented by the
active probes as the preliminary start and end (Table 1).
For a subset of six candidate sRNA genes, we deter-
mined the transcriptional start site (TSS) of the sRNAmolecules using the 50 rapid amplification of cDNA
ends- (50 RACE) technology (Invitrogen). The TSS of the
analysed sRNAs is shown in Table 1. 50 RACE was
conducted for two known sRNA genes, fasX and
sRNASpy490822 (CRISPR1), for one candidate predicted
by MOSES (MOSES4), and for three novel sRNA
candidates, sRNASpy490483c, sRNASpy491311c, and
sRNASpy491738. The results of the 50 RACE analysis are
shown in Figure 2. Promoter and terminator predictions
for the respective sRNA candidate genes are also included.
Comparison of the sRNA expression data using different
sRNA screens
The tiling array data were compared with the prediction
results of two recently published bioinformatics tools,
sRNAScanner [21] and MOSES [19]. As shown in
Figure 3A, the overlap between the GAS M49 array data
and the sRNA predictions performed with the sequence
of the NZ131 genome was minimal. From 20 MOSES
candidates, five were detected in the tiling array analysis,
while from 137 sRNAScanner predictions, 11 showed a
signal in the array. Eight putative sRNAs were selected
by both programs. There was only one sRNA that was
predicted by both algorithms and was also detected in
the tiling array (Figure 3A). The general accuracy of the
three independent screens was supported by the fact
that this mutual candidate was the known streptococcal
sRNA FASX [17].
We also compared our tiling array data with a previ-
ously published sRNA microarray study in GAS M1T1












Figure 1 Circular representation of the GAS M49 genome. Tracks from outermost moving inward: Track 1, NZ131 genome; Tracks 2 and 3,
presence of coding genes on the forward and reverse strand, respectively; Tracks 4 and 5, sRNA genes forward and reverse, respectively. Tracks 6
and 7 show the GC plot and the GC skew of the genome.
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http://www.biomedcentral.com/1471-2164/13/550Even though the sequences of the candidates were
conserved across streptococcal genomes, serotype-specific
variation of sRNA transcript abundance was observed in
northern blot experiments. Screening of GAS M1T1 was
conducted with cells grown in complex medium [20],
whereas the expression experiments in this study were
performed with GAS M49 grown in CDM. Consequently,
we found only a limited overlap between the two micro-
array screens (Figure 3B). Twelve sRNA candidates were
detected in both strains.
Analysis of common motifs in the GAS M49 sRNA
population
To identify putative functional regions within the sRNA
candidates, all sequences were screened for common
features by motif-based sequence analysis using MEME
SUITE [27]. The occurrence of shared sequence motifs
in different sRNA species could be an indication of com-
mon structural properties with functional significance in
this region. Seven motifs were identified with consensus
sequences with p-values < 1.0 ×10-7, spanning 9–27 base
pairs (Figure 4). Putative motif sequences were com-
pared to members of the Rfam database families, andwere subjected to TOMTOM [28] motif analysis using
the RegTransBase prokaryotic database. Candidates
sRNASpy490592 and sRNASpy491336c shared a 14 bp
consensus sequence with no apparent known function
(motif 4, Figure 4). For all other identified motifs, a
known function could be assigned to the respective
candidates. The corresponding RNAs were either
predicted to be RNAs with non-regulatory functions, e.g.
RNAseP (motif 5, Figure 4), or more typically, to represent
cis-regulatory RNA elements, e.g. FMN riboswitch or MET
box (motif 6 and motif 7, Figure 4).
Regulated expression of sRNA genes in GAS M49
Regulation of sRNA gene expression in GAS M49 under
different growth conditions was studied by intergenic
tiling array analyses. Total RNA was isolated from bacteria
grown in CDM, BHI, or THY. Samples were collected in
the exponential and stationary phases. Transcript level
changes were expressed as the log2 signal ratio between
conditions, and are listed in Table 2. sRNA gene expression
was considered significantly different when the log2 ratio of
the signals was ≤ −1.58 or ≥ 1.58. Twenty-four sRNA genes
were regulated in a growth phase- and/or medium-
FASX 
































Figure 2 Determination of the transcriptional start site of putative sRNAs. Transcriptional start sites were detected by 50 RACE-PCR and are
depicted in black/bold. The sequenced sRNA sequence is depicted in black, predicted RNA sequences are depicted in grey, predicted promoter
regions are depicted in blue, predicted rho-independent transcription terminators are depicted in green. The start codon of down-stream genes
is depicted in orange.
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http://www.biomedcentral.com/1471-2164/13/550dependent fashion. During growth in CDM, five genes were
up-regulated in the stationary growth phase compared to
the exponential growth phase, whereas three genes were
down-regulated. One of the down-regulated sRNA genes
was fasX. This is in accord with previous results, where a
reduction in fasX transcript abundance in the stationary
growth phase was detected by northern blot analysis [17].
This observation was also confirmed by qRT-PCR analyses
(Figure 5B). Comparison of sRNA gene expression during
growth in THY with expression during growth in CDM
revealed differential expression of 17 sRNA genes. Of these,
13 genes were down-regulated and four up-regulated in
THY. Growth in BHI led to the detection of 12 media-
dependent controlled sRNA genes. Nine genes were down-
regulated and three were up-regulated during growth in
BHI compared to growth in CDM. From the 20 sRNA
genes that showed media-dependent regulation, seven were
regulated in both THY and BHI, and showed the same
direction of regulation compared to CDM. Twelve sRNAgenes were exclusively regulated in one of the two media,
and only one gene was down-regulated in THY but up-
regulated in BHI compared to CDM. These results are in
accord with the fact that both media THY and BHI are
complex media, as opposed to the synthetic medium CDM,
which forces the bacteria to synthesize a number of compo-
nents essential for growth. Thus, in CDM, changes in
bacterial metabolism are necessary for successful growth
and require adaption of the bacterial transcriptome,
including the sRNAome.
Validation of sRNA expression by qRT-PCR and northern
blot analyses
Expression of sRNA candidates by GAS M49 was tested
by gene-specific reverse transcription followed by real-
time PCR analysis. Experimental expression validation
was performed for the RNAs FASX and sRNASpy490822
(CRISPR1), for the sRNA scan7, which was predicted


















Figure 3 Venn diagrams describing the relationships between
three different sRNA screens of two S. pyogenes genomes. A:
Comparison of the outcome of two bioinformatics screens and one
tiling array analysis of the S. pyogenes NZ131 genome. The total
number of candidates is shown for each of the three screens.
Candidates identified in more than one screen are represented by
the respective overlapping sections. B: The total number of
candidates is shown for two tiling array experiments in S. pyogenes
M49 (this study) and M1T1 [20], respectively. Candidates identified in
both screens are shown in the overlapping section.
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http://www.biomedcentral.com/1471-2164/13/550identified by tiling arrays in this study (sRNASpy490380c,
sRNASpy490957c, and sRNASpy491311c). The expression
of the candidates in GAS M49 was verified. Moreover, we
confirmed the orientation of the sRNA genes by employing
single gene-specific primers for the reverse transcription
reaction. Three reactions were performed in parallel: one
including the forward primer, one including the reverse
primer, and one without any primers. Signals were only
detected in samples containing the primer complementary
to the coding strand of the respective gene (data not
shown). We compared sRNA expression of GAS M49 cul-
tured in CDM medium and THY broth throughout growth
(Figure 5). 5S RNA was used as an internal control for
normalization, and was expressed in comparable amounts
under all conditions tested in this experiment. Expression
of fasX was equivalent during growth in CDM and THY
(Figure 5A). FASX was down-regulated in the stationary
phase, an observation that confirmed the array data and
previously published results from northern blot analyses
[17]. We did not detect strong regulation of CRISPR1,
sRNASpy490957c, or sRNASpy491311c during growth inCDM (Figure 5B). In contrast, scan7 was highly up-
regulated in the stationary phase (Figure 5B). The expres-
sion of sRNASpy490380c was much higher in THY com-
pared to CDM (almost 100-fold, data not shown). During
growth in CDM, no changes in the low level expression of
sRNASpy490380c were observed (data not shown).
To further verify candidate gene expression, northern
blot analysis of the same putative sRNA genes was per-
formed (Figure 6). This method allows the determination
of approximate transcript sizes. Probes specific for 5S RNA
and FASX were included as controls. The apparent mo-
lecular weight of candidates CRISPR1, sRNASpy490380c,
sRNASpy490483c, sRNASpy491311c, and scan7 corre-
sponded to the length predicted by 50 RACE determin-
ation. The CRISPR transcript, tracrRNA, showed a band at
the expected size of 176 nucleotides, as well as several
smaller bands that were likely the result of RNA proces-
sing, as observed previously in GAS M1T1 [29] (Additional
file 1A). For the putative sRNASpy490957c, transcript
analysis by 50 RACE predicted a 161 nt full-length product,
including the terminator region. However, the most prom-
inent band detected by northern blot analysis migrated at
approximately 80 nt. Low intensity bands were detected at
approximately 90 nt and 160 nt (Additional file 1B), which
might indicate post-transcriptional sRNA processing.
Discussion
Bacterial gene regulation by sRNAs has gained a lot of
attention in recent years, because it plays an important
role in many cellular processes, including response to
environmental changes, growth, and pathogenesis. There is
an intriguingly large diversity of regulatory mechanisms,
including cis- and trans-acting sRNAs, untranslated
regions, and riboswitches. Some sRNA molecules act as
repressors of translation and destabilize mRNA transcripts,
but others act by activating and stabilizing target mRNAs
[30-32]. One of the best characterized sRNAs in GAS is
FASX, which is involved in virulence-related gene regula-
tion [17,33]. Knock-out mutants of fasX show a reduced
expression of secreted virulence factors such as streptokin-
ase and streptolysin S. The mechanism for streptokinase
gene (ska) expression control is the stabilization of the ska
transcript [33]. Lack of FASX-ska-mRNA-interaction in
the fasX deletion mutant decreased transcript levels, and
consequently decreased streptokinase protein abundance.
A second example of a regulatory RNA in GAS is the
untranslated mRNA of the streptococcal pleiotropic
effect locus (pel), which contains sagA, the structural
gene for streptolysin S. This region was described as a
positive regulator of important streptococcal virulence
factors, including M-protein, Sic, and SpeB [34]. Strain
specificity of PEL function is indicated by the fact that
emm transcription was not affected in a sagA-deficient
mutant with a M6 background [35]. Similar results have







































Figure 4 Shared sequence motifs in sRNA candidates. aRfam, bTOMTOM.
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http://www.biomedcentral.com/1471-2164/13/550been obtained in GAS M1 and M18 Tn916 sagA mutant
strains [36]. Additionally, pel deletion mutant analysis of
four M1T1 GAS isolates did not identify any regulatory
function for the pel sRNA in this serotype [20].
Another, more recently described untranslated RNA
with influence on streptococcal virulence is the 4.5S
RNA, a component of the bacterial signal recognition
particle (SRP) [37]. While the 4.5S RNA gene is not
essential, mutation impairs bacterial growth, lowers
virulence factor secretion, and reduces virulence in a
mouse infection model.
Recently, several whole genome sRNA screens in
Gram-positive bacteria, employing either tiling array or
next generation sequencing approaches, revealed an unex-
pected number of potential sRNAs in several pathogenic
species [38-42]. In this context, it is likely that GASexpresses more sRNAs responsible for virulence gene
expression control. One whole-genome intergenic tiling
array screen of GAS M1T1 identified approximately 40
sRNAs that were expressed during the exponential growth
phase in cells cultivated in THYcomplex medium [20]. The
GAS M49 sRNAome in the present study was determined
using cells grown in CDM. From 55 putative sRNAs in
GAS M49, only 12 were detected previously in the GAS
M1T1 screen (Figure 3B). This result is in accord with the
concept that sRNA expression is serotype-dependent and
regulated by environmental stimuli. Consequently, we
detected media- and growth-phase-dependent sRNA gene
regulation in the tiling array expression analysis, or by qRT-
PCR of selected candidate genes. It would be interesting to
monitor sRNA gene expression regulation under infection-
relevant conditions.
Table 2 Regulation of S. pyogenes M49 sRNA gene expression dependent on culture medium and growth phase
















2 sRNASpy490206 −1,78 −2,00
3 sRNASpy490238 3,33








12 sRNASpy490845c −1,98 2,03
13 sRNASpy490957c −2,67
14 sRNASpy491007c −1,73 −1,81 1,94
15 sRNASpy491023c −1,84 1,92 3,54
16 sRNASpy491206c 1,58 2,65 −2,41
17 sRNASpy491311c −2,20
18 sRNASpy491561c −1,99




23 sRNASpy491732c −2,38 −3,60
24 sRNASpy491738 −3,40 −2,07 −4,30
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http://www.biomedcentral.com/1471-2164/13/550Clustered, regularly interspaced, short palindromic
repeat (CRISPR) loci represent an adaptive RNA-based
immune system that protects bacteria and archaea from
horizontal transfer of phage and plasmid DNA [43].
Among the putative sRNA genes detected in GAS M49 by
the tiling array approach, two sequences were categorised
by the Rfam prediction program as CRISPR-related RNAs
(Table 1). sRNASpy490822 and sRNASpy490827 are
encoded by the system II (Nmeni/CASS4 subtype) [44]
CRISPR/Cas locus, which was characterized recently by
differential RNA sequencing in GAS SF370 (M1 serotype)
[29]. Our data suggest that this locus is also active in GAS
M49. Expression of sRNASpy490822 was confirmed by
RT-PCR on the opposite strand of the CRISPR-associated
genes under all conditions tested in this study. This tran-
script corresponds to the trans-activating CRISPR RNA
(tracrRNA), which is responsible for the maturation of
CRISPR RNA in concert with RNase III and the CRISPR-
associated Csn1 protein [29]. A third CRISPR-related RNA
detected in our expression screen, sRNASpy491206c, is
encoded in the system I-C (Dvulg/CASS subtype) [44]CRISPR/Cas locus, which is also conserved in streptococcal
genomes. In contrast to our array data, this locus appeared
to be silent in GAS SF370, where no expression was
detected in the differential RNA sequencing approach [29].
Even though the CRISPR loci are conserved throughout
GAS genomes, the activity of different CRISPR subtypes
appears to be serotype-specific.
In the early years of sRNA research, many bioinfor-
matic prediction tools were developed. One of the most
prominent programs was the SIPHT tool, which has
been used for many bacterial species [45,46]. However,
comparison of the prediction results with the actual
in vivo expression of sRNAs often revealed very little
overlap between the different screening methods
[20,41,47]. The reasons for this discrepancy may be the
limitations of the prediction programs as well as the fact
that not all sRNAs are expressed under all conditions.
The development of sRNA prediction software with
improved properties is on-going. We compared our tiling
array data with the prediction results of two recently


























































Figure 5 Expression of sRNA candidates verified by qRT-PCR analysis. A: sRNA expression during growth in CDM compared to growth in
THY. Samples were taken during the exponential growth phase (OD600 = 0.4). Relative sRNA gene expression in CDM is depicted in this graph
(expression in THY is normalised to one). B: sRNA gene expression throughout growth in CDM. Samples were taken in the exponential growth
phase (OD600 = 0.4) and in the stationary phase (OD600 = 1.2). Relative sRNA gene expression at OD600 = 1.2 is depicted in this graph
(OD600 = 0.4 is normalised to one).
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between the tiling array expression data and the sRNA
predictions was low. From the 20 most probable candidates
of the MOSES analysis, 25% were expressed in GAS M49,
whereas 8% of the predicted sRNAScanner predictions
were found in the array analysis. Even the overlap between
the two bioinformatics data sets was low. The only sRNA
that was detected in all three screens was the previously
characterized sRNA FASX [17]. These results strongly
suggest that a comprehensive analysis of bacterial genomes
requires the combination of mathematical predictions
with the collection of expression data. In the long term,
testing of different conditions, especially mimicking in vivo
situations by employing infection models, might lead to an
increased overlap of expression detection and bioinfor-
matics analyses.
Conclusions
We present here the identification of 55 putative sRNAs
in GAS M49 by an intergenic tiling array approach. The
candidate sRNA genes were expressed during growth in
CDM. Forty-two of the RNAs were novel, whereas 13
RNAs have been described previously. The sequences ofmost of the candidates were conserved over streptococcal
genomes. However, comparison of our GAS M49 sRNA
expression data to another array analysis of a GAS M1
strain, and to two in silico screening methods, revealed
little overlap between the different approaches. Thus, the
investigation of several conditions and the combination
of screening tools will be necessary to gain a comprehensive
understanding of the abundance of sRNAs in GAS. The
identification of novel differentially expressed sRNA genes
will enhance our understanding of virulence related gene
regulation in GAS. To account for specific expression
patterns of putative sRNAs, infection relevant conditions
combined with next generation RNA sequencing should
be employed to investigate sRNA dependent regulatory
networks in GAS.
Methods
Bacterial strains and culture conditions
GAS serotype M49 strain 591, a clinical isolate from a
skin infection, was kindly provided by R. Lütticken
(Aachen, Germany). The GAS strain was cultured in
chemically defined medium (CDM) [48], Todd-Hewitt
broth (Invitrogen) supplemented with 0.5% yeast extract
CDM THY
0.4 0.8 1.2 0.4 0.8 1.2


























Figure 6 Confirmation of sRNA candidate expression by northern blot analysis. sRNA expression during growth in CDM and in THY
medium. 0.4: exponential growth phase (OD600 = 0.4); 0.8: transitional growth phase (OD600 = 0.8); 1.2: stationary growth phase (OD600 = 1.2). The
probes were specific for the RNAs indicated on the right of each blot. For comparison, the approximate sizes of the sRNA candidates, as
determined by 50RACE analysis, are indicated on the far right.
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(BHI; Oxoid), as indicated, at 37°C under a 5% CO2/20%
O2 atmosphere.
RNA isolation
Total bacterial RNA from cultures grown to exponential
and stationary phase of growth was isolated using the
FastRNAProBlue Kit from MP Biomedicals according to
manufacturer’s instructions. The purified total RNA was
digested with DNaseI (Ambion) to remove remaining
traces of chromosomal DNA. The RNA preparation was
treated with 10 U of DNase1 for 30 min at 37°C. The
enzyme was subsequently heat inactivated at 72°C for
5 min.
Enrichment of small RNAs
Five micrograms of total RNA were fractionated using the
Ambion FlashPAGE Fractionator, Ambion FlashPAGE
Precast Gels, and the Ambion FlashPAGE Buffer Kit,
following manufacturer’s instructions. To collect the
fraction of RNA molecules <200 nucleotides in length,
the protocol was modified by increasing the running time
from 12 min to up to 45 min at 75 V.Labelling
The small RNA fraction was ethanol-precipitated over-
night at −20°C. The RNA was pelleted by centrifugation,
dissolved in nuclease-free water, and labelled using the
Ambion mirVana miRNA Labeling Kit following the
manufacturer’s instructions. In brief, this kit involves two
main steps; the 30 amine-modified tailing reaction, and
labelling with NHS-esters. Poly(A) Polymerase and a
mixture of unmodified and amine-modified nucleotides
were used to add a 20–50 nucleotide tail to the 30 end of
each RNA molecule in the sample. The amine-modified
RNA molecules were purified and coupled to amine-
reactive labelled biotin moieties as NHS-esters.
Design and synthesis of microfluidic microarrays
We used a microfluidic biochip (Febit Biomed) consisting
of eight independent reaction chambers, the arrays,
enclosed in a cartridge for fully automated processing.
Each array contains 15,625 features which are synthe-
sized in situ inside the microchannels using the Geniom
One technology (febit biomed) [49]. The 50mer probes
were designed as a whole genome tiling array, covering
the intergenic regions of the S. pyogenes NZ131 genome
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reverse oriented probes were synthesized in separate
arrays. Thus, two arrays per sample were used.
Microarray hybridization and detection
All hybridization and detection steps were carried out using
a Geniom RT Analyzer (febit biomed). Hybridizations were
performed overnight (16 hours) at 42°C. Subsequently,
biotin was detected with streptavidin-phycoerythrin
(SAPE). A signal amplification step was added using bioti-
nylated anti-streptavidin antibodies (Vector Laboratories)
and a second incubation with SAPE (Invitrogen). Signal
detection using the appropriate filter set (Cy3) of the
Geniom device employed the auto-exposure function of the
Geniom software. The data discussed in this publication
have been deposited in the NCBI Gene Expression
Omnibus [50] and are accessible through GEO Series
accession number GSE31228 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE31228).
Microarray data analysis
Raw intensities were analysed and extracted using Geniom
Wizard software (febit biomed) as a tab delimited text file.
The data were then converted into a matrix, with rows
corresponding to the features and columns corresponding
to the different samples. Data analysis was performed
using GeneSpring GX (version 11) software (Agilent
Technologies). The array background was calculated as the
median signal intensity of all “blank-control” features on
the array. Data were background corrected and then nor-
malized using quantile normalization [51]. Following
normalization, a quality control step was performed that
removed all data sets with a correlation coefficient less than
0.9 compared to the corresponding biological replicates. Of
the original four biological replicate data sets representing
cells grown in CDM, at least three were included in the
analysis. The remaining probes of the biological replicates
required intensity values greater than 300 on all three
arrays. Regions that showed signals on probes of both
strands were manually removed following the primary
analysis. The statistical significance of the determined sig-
nals was tested by unpaired student’s t-test with a false dis-
covery rate of 5%. Resulting data were combined with gene
information from the flanking coding regions. Terminators
and promoters were predicted by TransTermHP [52]
(http://transterm.cbcb.umd.edu/tt/Streptococcus_pyogenes
_NZ131.tt) and BDGP Neural Network Promoter
Prediction [53], and BProm (www.SoftBerry.com), respect-
ively. To investigate sRNA gene regulation, two biological
replicates of growth experiments conducted in THY or
BHI were included. Following data normalization, three-
fold signal intensity differences between various conditions
were determined using the GeneSpring GX (version 11)
software (Agilent Technologies). A motif search wasconducted using MEME Suite [27], followed by motif
analyses using TOMTOM [28], (http://meme.sdsc.edu/
meme/intro.html).
50 RACE
The transcriptional start sites of sRNA candidates were
determined using 50 RACE (Invitrogen) following the
manufacturer’s instructions. Briefly, first strand cDNA
was synthesized using gene-specific primers (Additional
file 2). The original mRNA was enzymatically removed
and the 30 end of the cDNA was tailed with dCTP by
terminal deoxynucleotidyl transferase (TdT). PCR ampli-
fication was performed with nested, sequence-specific
primers and an anchor primer provided by the 50 RACE
system. Primers specific for the sRNA genes tested here
are listed in Additional file 2. Following amplification,
PCR products were cloned into a TOPO-TA vector
(Invitrogen) and sequenced (GATC Biotech AG).
Quantitative reverse transcription PCR
Acidic phenol-extracted, DNaseI-treated total RNA was
reverse transcribed to generate cDNA using the First-
Strand cDNA Synthesis Kit from Invitrogen following
the protocol provided by the manufacturer. For gene-
specific reverse transcription (RT), three reactions were
performed: two strand-specific reactions with either one
forward or one reverse primer, and one control reaction
without any primer. Primers were designed based on the
full genome sequence of S. pyogenes M49 strain NZ131
(NCBI accession number: NC011375) and are listed in
Additional file 3. Three independent RT experiments
were performed and all subsequent PCR reactions were
performed in triplicate. Primer efficiency was tested on
genomic GAS M49 DNA prior to use in RT reactions.
All cDNA products were amplified by PCR with two pri-
mers specific for the respective candidate sequences.
Real time PCR amplification was performed with SYBR
Green (Fermentas) using an ABI PRISM 7000 Sequence
Detection system (Applied Biosystems). The level of 5S
RNA gene transcription was used for normalization.
Relative gene expression was determined by the ΔΔCT
method [54].
Northern blot analyses
Total RNA was isolated during exponential (OD600 = 0.4),
transitional (OD600 = 0.8), and stationary (OD600 =1.2)
growth phases. RNA samples (10 μg per growth phase)
were loaded onto an 8% TBE-Urea polyacrylamide gel and
separated by electrophoresis. Size standards (Ultra Low
Range Ladder, Fermentas) were loaded on the same gel.
RNA was electroblotted onto positively charged nylon
membranes (Ambion), UV cross-linked, and probed over-
night with a probe complementary to a candidate sRNA.
Probes were generated by PCR with the same primers as
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in Additional file 3). Probes were labelled with biotin prior
to hybridization (Brightstar psoralen-biotin labeling kit,
Ambion). A BrightStar BioDetect Kit (Ambion) was used
for detection, and autoradiography films were exposed to
the luminescent blots.
Additional files
Additional file 1: A: northern blot analysis of CRISPR gene
expression and transcript processing in GAS M49; B: northern blot
analysis of sRNASpy490957c gene expression in GAS M49.
Additional file 2: Sequences of primers used for 50 RACE.
Additional file 3: Sequences of gene-specific primers employed for
qRT-PCR.
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